Jentadueto 2.5 mg - 1000 mg (linagliptine + metformine) · CNK 2926368

Product information

Product name
Jentadueto 2.5 mg - 1000 mg
Pack
60 (60 x 1)
Active ingredient
linagliptine + metformine
CNK Code
2926368
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
668270-12-0
ATC code
A10BD11
Company
Boehringer Ingelheim International
Pharmaceutical form
Film-coated tablet
Ex-factory price
€34.03
Authorisation number
EU/1/12/780/020
GTIN
04048846015495
Delivery mode
M1
Delivery environment
Public
CTI Extended
425661-01

Pharmacist Assessment

Assessment title
Commercialization officially ended — no stock
Assessment description

SAM has flagged this product as commercially stopped (reason: Insufficient demand) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Assessment alternative
Eucreas 50 mg - 850 mg (CNK 2564458) — Score: 7.94/10
Assessment alternative warning
Different strength — dose adjustment required. Consult the physician.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives
Parallel import available 1 Magistral alternative available 2

Status history (PharmaStatus)

Commercialization stopped Active
- present

Insufficient demand

Alternative available

Composition

3 ingredients

Ingredients
Substance Type Strength CAS
Substance
Linagliptine
Type
Active ingredient
Strength
2.5 mg
CAS
668270-12-0
Substance
Metforminehydrochloride
Type
Active ingredient
Strength
1000 mg
CAS
1115-70-4
Substance
Propyleenglycol
Type
Excipient
Strength
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
396 days
Number of status changes
2
Active supply problems
0
Last change
01/01/2026